| 2016-10-19 16:09:48|
AVGR 16:09 10/19 10/19/16
Avinger announces expanded FDA indications for Pantheris
Avinger announced that the company has received expanded indications from the FDA recognizing the Pantheris Lumivascular atherectomy system as a technology that can be used for both therapeutic and diagnostic purposes. Pantheris is the first and only image-guided atherectomy device to receive clearance for diagnostic imaging as well as for the simultaneous treatment of PAD. This expanded indication clarifies that, in addition to treatment of PAD, Pantheris may be used by physicians to identify the vessel lumen and wall structures such as intima, internal elastic lamina, media, external elastic lamina and stent struts, as well as vessel morphologies such as calcium, thrombus, fibroatheromas, and necrotic cores.